Warrants (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Warrants and Rights Note Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Fair Value Method to Allocate Net Proceeds Received from Sale of Common Stock and Pre-funded Warrants | The Company used the relative fair value method to allocate the net proceeds received from the sales of the PIPE Shares and the 2023 Pre-Funded Warrants on the consolidated balance sheet as follows (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Assumptions Used To Estimate Fair Value Of Warrants | The following assumptions were used to estimate the fair value of the warrants at issuance:
The Company estimated the fair value of the SSI Warrant liability using the following assumptions as of March 31, 2025:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Warrant Liability | The following table summarizes changes in the Company’s warrant liability during the three months ended March 31, 2025 (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||